Clinical significance of the determination of lidocaine and anti-arrhythmic drugs in acute myocardial infarct
Matta, F.; De Marchi, M.; Pecchio, F.; Bevilacqua, R.; Aillon, A.; Piccinino, C.; Riva, L.; Alvino, A.; Angelino, P.F.
Minerva Cardioangiologica 29(4): 131-136
1981
ISSN/ISBN: 0026-4725 PMID: 7242944 Document Number: 179711
Document emailed within 1 workday
Related Documents
Chung, E.K. 1973: The prophylactic use of anti-arrhythmic drugs in acute myocardial infarction Singapore Medical Journal 14(3): 205-210Széplaki, S.; Szilágyi, A.; Böszörményi, E.; Barsi, B.; Máté, K.; Kulcsár, M. 1974: Anti-ischemic effect of lidocaine in the acute phase of myocardial infarct without shock Orvosi Hetilap 115(12): 671-675
Topolcan, O.; Karlícek, V.; Kratochvíl, Z.; Polívková, A.; Dvorák, I. 1988: Prognostic significance of radioimmunologic determination of myoglobin in acute myocardial infarct Vnitrni Lekarstvi 34(8): 729-733
Forfang, K.; Lippestad, C.T. 1971: Adverse effects of lidocaine as an anti-arrhythmic drug Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 710-713
Banshchikov, G.T.; Gudkov, G.Ia.; Zinovenko, T.N.; Mazur, N.A. 1983: Lidocaine prevention of ventricular fibrillation in acute myocardial infarct at the first-aid and early hospital stages Kardiologiia 23(5): 80-82
Rolli, A.; Bonatti, V.; Finardi, A.; Favaro, L.; Botti, G. 1981: Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias Giornale Italiano di Cardiologia 11(4): 468-476
Singh, B.N. 1973: Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias New Zealand Medical Journal 78(504): 482-486
Tavazzi, L.; Guagliumi, G.; Galli, M. 1985: Significance of ST segment depression in patients with acute and non-acute inferior myocardial infarct Giornale Italiano di Cardiologia 15(2): 165-168
Beck, O.A.; Vogt, J.; Hochrein, H. 1978: The comparative hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction (comparison of propafenone and lidocaine) Zeitschrift für Kardiologie 67(1): 41-45
Ambrosioni, E.; Degli Esposti, D. 1991: Thrombolytic drugs in acute myocardial infarct Cardiologia 36(12 Suppl 1: 395-402
Dobrotvorskaia, T.E.; Shchukov, A.A.; Gordina, O.V.; Suprun, E.K.; Shardanov, N.A.; Kandoeva, M.M. 1994: The clinical and hemodynamic effects of enalapril and its influence on the peri-infarct area in patients with an acute myocardial infarct Terapevticheskii Arkhiv 66(8): 16-19
De Marchi, M.; De Bernardi, A.; Sclavo, M.G.; Bevilacqua, R.; Piccinino, C.; Minelli, M.; Bottone, W.; Angelino, P.F. 1981: Significance of hemodynamic monitoring in acute myocardial infarct Minerva Cardioangiologica 29(4): 115-122
Kolár, J.; Kozená, J. 1971: Significance of cardiac stimulation in acute myocardial infarct Casopis Lekaru Ceskych 110(49): 1140-1143
Platek, H. 1973: Anti-arrhythmic drugs Wiadomosci Lekarskie 26(7): 623-627
Pachinger, O.; Punzengruber, C. 1988: Thrombolytic therapy of acute myocardial infarct: which drugs? which patients? Wiener Medizinische Wochenschrift 138(15-16): 373-379
András, J.; Iván, G.; Andrástné, C. 1976: Determination of late prognosis of acute myocardial infarct Orvosi Hetilap 117(51): 3091-3095
Weiss-Simon, C.; Spangenberg, G.; Michel, D. 1980: Anti-arrhythmic agents. 2. Special anti-arrhythmic effect, known drug interactions Fortschritte der Medizin 98(15): 569-572
Yamauchi, Y.; Maesako, N.; Horimatsu, T.; Tanaka, K.; Isobe, T.; Imura, H. 1984: Determination of anti-DNA antibody levels using an anti-DNA kit and its clinical significance Nihon Rinsho. Japanese Journal of Clinical Medicine 42(8): 1930-1941
De Micheli, A. 1987: Development of anti-arrhythmic drugs Archivos del Instituto de Cardiologia de Mexico 57(1): 1-8
Noll, G.; Kaufmann, U.; Wenzel, R.R.; Lüscher, T.F. 1996: Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs Schweizerische Medizinische Wochenschrift 126(5): 164-176